Atıf Formatları
Fe3O4 Nanoparticles in Combination with 5-FU Exert Antitumor Effects Superior to Those of the Active Drug in a Colon Cancer Cell Model
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

S. GENÇ Et Al. , "Fe3O4 Nanoparticles in Combination with 5-FU Exert Antitumor Effects Superior to Those of the Active Drug in a Colon Cancer Cell Model," Pharmaceutics , vol.15, no.1, 2023

GENÇ, S. Et Al. 2023. Fe3O4 Nanoparticles in Combination with 5-FU Exert Antitumor Effects Superior to Those of the Active Drug in a Colon Cancer Cell Model. Pharmaceutics , vol.15, no.1 .

GENÇ, S., TAGHIZADEHGHALEHJOUGHI, A., YENİ, Y., Jafarizad, A., HACIMÜFTÜOĞLU, A., Nikitovic, D., ... Docea, A. O.(2023). Fe3O4 Nanoparticles in Combination with 5-FU Exert Antitumor Effects Superior to Those of the Active Drug in a Colon Cancer Cell Model. Pharmaceutics , vol.15, no.1.

GENÇ, SIDIKA Et Al. "Fe3O4 Nanoparticles in Combination with 5-FU Exert Antitumor Effects Superior to Those of the Active Drug in a Colon Cancer Cell Model," Pharmaceutics , vol.15, no.1, 2023

GENÇ, SIDIKA Et Al. "Fe3O4 Nanoparticles in Combination with 5-FU Exert Antitumor Effects Superior to Those of the Active Drug in a Colon Cancer Cell Model." Pharmaceutics , vol.15, no.1, 2023

GENÇ, S. Et Al. (2023) . "Fe3O4 Nanoparticles in Combination with 5-FU Exert Antitumor Effects Superior to Those of the Active Drug in a Colon Cancer Cell Model." Pharmaceutics , vol.15, no.1.

@article{article, author={SIDIKA GENÇ Et Al. }, title={Fe3O4 Nanoparticles in Combination with 5-FU Exert Antitumor Effects Superior to Those of the Active Drug in a Colon Cancer Cell Model}, journal={Pharmaceutics}, year=2023}